EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Rezafungin for sternal wound infection caused by multidrug-resistant Candidozyma auris: a case report

Suvitesh Luthra iD, Annette David iD, David Thirukumaran, Tat Shing Yam

Access Microbiology · 01.11.2026 · 8 (11)

DOI: 10.1099/acmi.0.001171.v4 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Access Microbiology, erschienen am 01.11.2026. Verfasst von Suvitesh Luthra und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Southampton National Health Service Foundation Trust, Southampton, UK. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Candidozyma auris is an emerging multidrug-resistant fungal pathogen associated with healthcare outbreaks and significant mortality. Management can be challenging due to antifungal resistance and the need for prolonged intravenous therapy. Case Presentation. A 58-year-old man developed a postoperative sternal wound infection caused by multidrug-resistant C. auris following aortic valve replacement, coronary artery bypass grafting and ascending aortic interposition graft surgery. His postoperative course was complicated by Staphylococcus epidermidis prosthetic graft infection requiring redo valve replacement and graft repair and placement of vacuum-assisted closure. Two weeks after discharge home, persistent wound discharge yielded C. auris . Following surgical debridement and initiation of intravenous caspofungin with oral itraconazole, once-daily intravenous antifungal therapy was transitioned to once-weekly intravenous rezafungin to facilitate outpatient treatment coordinated with vacuum-assisted wound therapy.

Conclusion

After 12 weeks of dual antifungal therapy, complete clinical and microbiological resolution was achieved without adverse events. This case highlights the feasibility of rezafungin as an outpatient treatment strategy for complex multidrug-resistant C. auris infections.

Schlagwörter

Stichwörter der Autor:innen

Candidozyma aurisechinocandinmultidrug resistanceoutpatient antifungal therapyrezafunginsternal wound infection

Autor:innen und Institutionen

  • University Hospital Southampton National Health Service Foundation Trust, Southampton, UK.

ORCID-Profile: Suvitesh Luthra, Annette David

Zitieren

APA

Luthra, S., David, A., Thirukumaran, D., & Yam, T. S. (2026). Rezafungin for sternal wound infection caused by multidrug-resistant Candidozyma auris: a case report. Access Microbiology, 8(11). https://doi.org/10.1099/acmi.0.001171.v4

Vancouver

Luthra S, David A, Thirukumaran D, Yam TS. Rezafungin for sternal wound infection caused by multidrug-resistant Candidozyma auris: a case report. Access Microbiology. 2026;8(11). doi:10.1099/acmi.0.001171.v4

BibTeX
@article{Luthra2026,
  author = {Luthra, Suvitesh and David, Annette and Thirukumaran, David and Yam, Tat Shing},
  title = {Rezafungin for sternal wound infection caused by multidrug-resistant Candidozyma auris: a case report},
  journal = {Access Microbiology},
  year = {2026},
  volume = {8},
  number = {11},
  doi = {10.1099/acmi.0.001171.v4}
}
Kostenlos starten →